PL2253330T3 - Skoniugowane cząsteczki biologiczne i ich otrzymywanie - Google Patents
Skoniugowane cząsteczki biologiczne i ich otrzymywanieInfo
- Publication number
- PL2253330T3 PL2253330T3 PL10175140T PL10175140T PL2253330T3 PL 2253330 T3 PL2253330 T3 PL 2253330T3 PL 10175140 T PL10175140 T PL 10175140T PL 10175140 T PL10175140 T PL 10175140T PL 2253330 T3 PL2253330 T3 PL 2253330T3
- Authority
- PL
- Poland
- Prior art keywords
- group
- general formula
- protein
- compound
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F10/00—Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0316294.8A GB0316294D0 (en) | 2003-07-11 | 2003-07-11 | Conjugated biological molecules and their preparation |
| EP09167191.7A EP2133099B1 (en) | 2003-07-11 | 2004-07-12 | Conjugated biological molecules and their preparation |
| EP04743335A EP1648518B1 (en) | 2003-07-11 | 2004-07-12 | Conjugated biological molecules and their preparation |
| EP10175140.2A EP2253330B1 (en) | 2003-07-11 | 2004-07-12 | Conjugated biological molecules and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2253330T3 true PL2253330T3 (pl) | 2016-01-29 |
Family
ID=27742023
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10175140T PL2253330T3 (pl) | 2003-07-11 | 2004-07-12 | Skoniugowane cząsteczki biologiczne i ich otrzymywanie |
| PL04743335T PL1648518T3 (pl) | 2003-07-11 | 2004-07-12 | Skoniugowane cząsteczki biologiczne i ich wytwarzanie |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04743335T PL1648518T3 (pl) | 2003-07-11 | 2004-07-12 | Skoniugowane cząsteczki biologiczne i ich wytwarzanie |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US7595292B2 (pl) |
| EP (4) | EP2253330B1 (pl) |
| JP (2) | JP4958549B2 (pl) |
| KR (1) | KR101152500B1 (pl) |
| CN (2) | CN1822860B (pl) |
| AT (1) | ATE440620T1 (pl) |
| AU (2) | AU2004257448B2 (pl) |
| DE (1) | DE602004022824D1 (pl) |
| DK (4) | DK2133099T3 (pl) |
| ES (4) | ES2632515T3 (pl) |
| GB (1) | GB0316294D0 (pl) |
| PL (2) | PL2253330T3 (pl) |
| WO (1) | WO2005007197A2 (pl) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1667708T5 (da) | 2002-12-26 | 2012-11-12 | Mountain View Pharmaceuticals | Polyethylenglycolkonjugater af interferon-beta-1b med forøget biologisk styrke in vitro |
| GB0316294D0 (en) * | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
| US7046714B2 (en) * | 2003-09-10 | 2006-05-16 | Intel Corporation | Method and apparatus for Raman ring resonator based laser/wavelength converter |
| US7837980B2 (en) * | 2004-03-02 | 2010-11-23 | Seattle Genetics, Inc. | Partially loaded antibodies and methods of their conjugation |
| CA2619244A1 (en) * | 2005-08-15 | 2007-02-22 | Arana Therapeutics Limited | Engineered antibodies with new world primate framework regions |
| KR20090039666A (ko) * | 2006-02-01 | 2009-04-22 | 아라나 테라퓨틱스 리미티드 | 도메인 항체 구조체 |
| US20080139790A1 (en) * | 2006-12-08 | 2008-06-12 | Jennings Philip A | Chimeric antibodies |
| EP2118150B1 (en) | 2007-02-14 | 2015-09-23 | Biocompatibles UK Limited | Derivatisation of biological molecules |
| GB0708376D0 (en) | 2007-05-01 | 2007-06-06 | Alligator Bioscience Ab | Novel polypeptides and uses thereof |
| US8658148B2 (en) | 2007-06-22 | 2014-02-25 | Genzyme Corporation | Chemically modified dendrimers |
| TWI360535B (en) | 2007-08-30 | 2012-03-21 | Univ Nat Sun Yat Sen | Sulfur-containing compound, method of preparation |
| EP2209494B1 (en) * | 2007-10-09 | 2016-07-20 | Polytherics Limited | Novel conjugated proteins and peptides |
| EP2280734B1 (en) * | 2008-04-24 | 2014-02-26 | Cantab Biopharmaceuticals Patents Limited | Factor ix conjugates with extended half-lives |
| KR101678925B1 (ko) | 2008-06-30 | 2016-11-24 | 에스바테크 - 어 노바티스 컴파니 엘엘씨 | 기능화 폴리펩티드 |
| CA2730178A1 (en) | 2008-07-10 | 2010-01-14 | Esbatech, An Alcon Biomedical Research Unit Llc | Methods and compositions for enhanced delivery of macromolecules |
| JP5622117B2 (ja) | 2008-07-21 | 2014-11-12 | ポリテリクスリミテッド | 生体分子を接合するための新規な試薬及び方法 |
| GB0817978D0 (en) * | 2008-10-01 | 2008-11-05 | Imp Innovations Ltd | Peptides |
| AU2009313619A1 (en) * | 2008-11-04 | 2010-05-14 | Janssen Pharmaceutica Nv | CRHR2 peptide agonists and uses thereof |
| EP2403538B1 (en) | 2009-03-04 | 2017-10-04 | Polytherics Limited | Conjugated proteins and peptides |
| GB0912485D0 (en) | 2009-07-17 | 2009-08-26 | Polytherics Ltd | Improved conjugation method |
| GB0922354D0 (en) | 2009-12-21 | 2010-02-03 | Polytherics Ltd | Novel polymer conjugates |
| JP5906184B2 (ja) | 2009-06-22 | 2016-04-20 | バーナム インスティテュート フォー メディカル リサーチ | Ｃ末端エレメントを有するペプチドおよびタンパク質を使用する方法および組成物 |
| GB0916578D0 (en) | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| GB0916576D0 (en) | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| FI124016B (fi) * | 2009-10-26 | 2014-01-31 | Vapo Oy | Menetelmä biomassakuivattimessa käytetyn kuivatusilman lämmittämiseksi välipiirinesteen avulla sekä vesi-glykoliseoksen tai sitä vastaavan jäätymättömän välipiirinesteen käyttö biomassakuivattimessa käytetyn kuivatusilman lämmittämiseksi |
| AU2010315131A1 (en) | 2009-11-04 | 2012-05-31 | Janssen Pharmaceutica Nv | Method for treating heart failure with stresscopin-like peptides |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| GB201007357D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIII |
| WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
| GB2490655A (en) | 2011-04-28 | 2012-11-14 | Univ Aston | Modulators of tissue transglutaminase |
| EP2715291A4 (en) | 2011-05-31 | 2015-10-21 | Airware Inc | NON-DISPERSIVE GAS SENSORS WITH ABSORPTION INFRARED ABSORPTION (NDIR) |
| US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
| MD20140123A2 (ro) | 2012-04-16 | 2015-04-30 | Cantab Biopharmaceuticals Patents Limited | Agenţi terapeutici optimizaţi pentru administrare subcutanată |
| WO2013177481A1 (en) | 2012-05-25 | 2013-11-28 | Immunogen, Inc. | Benzodiazepines and conjugates thereof |
| US9650331B2 (en) | 2012-06-18 | 2017-05-16 | Polytherics Limited | Conjugation reagents |
| GB201210770D0 (en) | 2012-06-18 | 2012-08-01 | Polytherics Ltd | Novel conjugation reagents |
| MX2014015682A (es) * | 2012-06-19 | 2015-07-23 | Polytherics Ltd | Proceso novedoso para preparacion de conjugados de anticuerpo y conjugados de anticuerpo novedosos. |
| MY169147A (en) | 2012-10-24 | 2019-02-18 | Polytherics Ltd | Drug-protein conjugates |
| NO2789793T3 (pl) | 2012-10-24 | 2018-01-27 | ||
| MX2015006868A (es) | 2012-11-30 | 2015-10-05 | Novartis Ag | Metodos para la elaboracion de conjugados a partir de proteinas que contienen disulfuro. |
| WO2014093394A1 (en) | 2012-12-10 | 2014-06-19 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| WO2014093379A1 (en) | 2012-12-10 | 2014-06-19 | Mersana Therapeutics, Inc. | Auristatin compounds and conjugates thereof |
| US9872918B2 (en) | 2012-12-12 | 2018-01-23 | Mersana Therapeutics, Inc. | Hydroxyl-polymer-drug-protein conjugates |
| BR112015022585B1 (pt) | 2013-03-15 | 2023-04-04 | Regeneron Pharmaceuticals, Inc | Composto, composição farmacêutica, conjugado droga-anticorpo, e, uso dos mesmos |
| GB201308738D0 (en) * | 2013-05-15 | 2013-06-26 | Polytherics Ltd | Novel polymer conjugates |
| AU2014311361B2 (en) | 2013-08-26 | 2018-11-29 | Regeneron Pharmaceuticals, Inc. | Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses |
| SG11201601770YA (en) | 2013-09-12 | 2016-04-28 | Halozyme Inc | Modified anti-epidermal growth factor receptor antibodies and methods of use thereof |
| CN105813655B (zh) | 2013-10-11 | 2022-03-15 | 阿萨纳生物科技有限责任公司 | 蛋白-聚合物-药物缀合物 |
| CN105979970B (zh) | 2013-10-11 | 2019-09-10 | 梅尔莎纳医疗公司 | 蛋白质-聚合物-药物共轭物 |
| AU2014356126B2 (en) | 2013-11-26 | 2017-01-05 | Novartis Ag | Methods for oxime conjugation to ketone-modified polypeptides |
| GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| US10406198B2 (en) | 2014-05-23 | 2019-09-10 | Novartis Ag | Methods for making conjugates from disulfide-containing proteins |
| EP3148592A2 (en) | 2014-06-02 | 2017-04-05 | Regeneron Pharmaceuticals, Inc. | Antibody-drug conjugates, their preparation and their therapeutic use |
| GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
| EP3218009B1 (en) | 2014-10-14 | 2021-04-07 | Polytherics Limited | Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of peg |
| CN107667113B (zh) * | 2015-02-05 | 2022-05-03 | 埃博灵克斯股份有限公司 | 通过c端改造的半胱氨酸连接的纳米抗体二聚体 |
| US10098960B2 (en) | 2015-04-03 | 2018-10-16 | Ucl Business Plc | Polymer conjugate |
| WO2017025458A1 (en) | 2015-08-07 | 2017-02-16 | Gamamabs Pharma | Antibodies, antibody drug conjugates and methods of use |
| CN108350605A (zh) | 2015-09-04 | 2018-07-31 | 台湾浩鼎生技股份有限公司 | 聚糖阵列以及使用方法 |
| CN108473589B (zh) | 2016-01-12 | 2023-05-02 | 克雷森多生物制剂有限公司 | 结合前列腺特异性膜抗原(psma)的分子 |
| GB201601136D0 (en) | 2016-01-21 | 2016-03-09 | Mörgelin Matthias And Abdillahi Suado M | Novel polypeptides and medical uses thereof |
| MA43094B1 (fr) | 2016-01-25 | 2020-10-28 | Regeneron Pharma | Dérivés de maytansinoïde, leurs conjugués, et procédés d'utilisation |
| WO2017161206A1 (en) | 2016-03-16 | 2017-09-21 | Halozyme, Inc. | Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use |
| AU2017239637A1 (en) | 2016-03-29 | 2018-11-15 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| WO2017178828A1 (en) | 2016-04-14 | 2017-10-19 | Polytherics Limited | Conjugates and conjugating reagents comprising a linker that includes at least two (-ch2-ch2-0-) units in a ring |
| BR112018071683A2 (pt) | 2016-04-22 | 2019-02-19 | Obi Pharma, Inc. | método para tratar um câncer de mama, método para tratamento de um tumor em um paciente, método para tratar um indivíduo sofrendo com câncer por imunoterapia, método para induzir/melhorar uma resposta imune em um indivíduo, método para melhorar a vacina obi-822 induzida pela resposta imune em um indivíduo necessitando da mesma, método para identificar um paciente adequado para terapia do câncer e método para determinar o prognóstico do tratamento do câncer ou resposta do fármaco de um paciente |
| GB201608936D0 (en) | 2016-05-20 | 2016-07-06 | Polytherics Ltd | Novel conjugates and novel conjugating reagents |
| US11485792B2 (en) | 2016-06-06 | 2022-11-01 | Polytherics Limited | Antibodies, uses thereof and conjugates thereof |
| WO2018022933A1 (en) | 2016-07-27 | 2018-02-01 | Obi Pharma, Inc. | Immunogenic/therapeutic glycan compositions and uses thereof |
| US11643456B2 (en) | 2016-07-29 | 2023-05-09 | Obi Pharma, Inc. | Human antibodies, pharmaceutical compositions and methods |
| GB201615725D0 (en) | 2016-09-15 | 2016-11-02 | Polytherics Ltd | Novel cytotoxic agents and conjugates thereof |
| WO2018094414A1 (en) | 2016-11-21 | 2018-05-24 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| US11135307B2 (en) | 2016-11-23 | 2021-10-05 | Mersana Therapeutics, Inc. | Peptide-containing linkers for antibody-drug conjugates |
| JP7320458B2 (ja) | 2017-06-22 | 2023-08-03 | メルサナ セラピューティクス インコーポレイテッド | 薬物担持ポリマースキャフォールドおよびタンパク質－ポリマー－薬物コンジュゲートを製造する方法 |
| GB201711068D0 (en) | 2017-07-10 | 2017-08-23 | Crescendo Biologics Ltd | Therapeutic molecules binding PSMA |
| TW202035444A (zh) | 2018-06-27 | 2020-10-01 | 台灣浩鼎生技股份有限公司 | 用於糖蛋白工程的糖苷合成酶變體及其使用方法 |
| GB201814281D0 (en) | 2018-09-03 | 2018-10-17 | Femtogenix Ltd | Cytotoxic agents |
| GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
| GB201909298D0 (en) | 2019-06-28 | 2019-08-14 | Colzyx Ab | Novel compositions and uses thereof |
| GB2597532A (en) | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
| GB202016456D0 (en) | 2020-10-16 | 2020-12-02 | Colzyx Ab | Novel bioactive peptide combinations and uses thereof |
| WO2024013723A1 (en) | 2022-07-15 | 2024-01-18 | Pheon Therapeutics Ltd | Antibody drug conjugates that bind cdcp1 and uses thereof |
| CN115304524A (zh) * | 2022-07-21 | 2022-11-08 | 湖南大学 | 一种β-酰基烯丙基甲基砜类化合物及其高效合成方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US680343A (en) * | 1899-04-15 | 1901-08-13 | Johan Peter Moeller | Glove. |
| US3828412A (en) * | 1971-03-19 | 1974-08-13 | Dunham Bush Inc | Method of forming high integrity epoxy joint between aluminum tubes |
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPH01502118A (ja) | 1987-01-15 | 1989-07-27 | セルテク・リミテツド | チオール反応性架橋剤 |
| HUT64022A (en) | 1989-04-19 | 1993-11-29 | Enzon Inc | Process for producing active polyalkileneoxide carbonates for the modification of polypeptides |
| US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| CA2288429C (en) | 1991-03-15 | 2006-04-25 | Synergen, Inc. | Pegylation of polypeptides |
| AU5006993A (en) | 1992-08-21 | 1994-03-15 | Enzon, Inc. | Novel attachment of polyalkylene oxides to bio-effecting substances |
| US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
| WO1995025764A1 (fr) * | 1994-03-23 | 1995-09-28 | Meiji Seika Kabushiki Kaisha | Derive bicatenaire de lipide contenant un polyoxyethylene |
| US5877224A (en) * | 1995-07-28 | 1999-03-02 | Rutgers, The State University Of New Jersey | Polymeric drug formulations |
| GB9713979D0 (en) | 1997-07-03 | 1997-09-10 | Univ Nottingham | Method for attaching peg to macromolecules |
| WO1999045964A1 (en) * | 1998-03-12 | 1999-09-16 | Shearwater Polymers, Incorporated | Poly(ethylene glycol) derivatives with proximal reactive groups |
| US6153655A (en) * | 1998-04-17 | 2000-11-28 | Enzon, Inc. | Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| JP4574007B2 (ja) * | 1998-04-28 | 2010-11-04 | メルク・セローノ・ソシエテ・アノニム | ポリオール−ｉｆｎ−ベータ複体 |
| WO2001005819A1 (en) | 1999-07-15 | 2001-01-25 | Kuhnil Pharm. Co., Ltd. | Novel water soluble-cyclosporine conjugated compounds |
| WO2001017515A1 (en) | 1999-09-03 | 2001-03-15 | School Of Pharmacy, University Of London | Degradable polymers |
| US6828412B1 (en) | 1999-09-03 | 2004-12-07 | School Of Pharmacy, University Of London | Degradable polymers |
| ATE297954T1 (de) | 1999-09-08 | 2005-07-15 | Polytherics Ltd | Polymere mit uniformem molekulargewicht |
| GB0316294D0 (en) * | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
| GB0400264D0 (en) * | 2004-01-07 | 2004-02-11 | Polytherics Ltd | Complexes |
| EP2118150B1 (en) | 2007-02-14 | 2015-09-23 | Biocompatibles UK Limited | Derivatisation of biological molecules |
| EP2209494B1 (en) * | 2007-10-09 | 2016-07-20 | Polytherics Limited | Novel conjugated proteins and peptides |
| JP5622117B2 (ja) * | 2008-07-21 | 2014-11-12 | ポリテリクスリミテッド | 生体分子を接合するための新規な試薬及び方法 |
| EP2403538B1 (en) * | 2009-03-04 | 2017-10-04 | Polytherics Limited | Conjugated proteins and peptides |
| GB0912485D0 (en) * | 2009-07-17 | 2009-08-26 | Polytherics Ltd | Improved conjugation method |
| US9650331B2 (en) | 2012-06-18 | 2017-05-16 | Polytherics Limited | Conjugation reagents |
-
2003
- 2003-07-11 GB GBGB0316294.8A patent/GB0316294D0/en not_active Ceased
-
2004
- 2004-07-12 EP EP10175140.2A patent/EP2253330B1/en active Active
- 2004-07-12 PL PL10175140T patent/PL2253330T3/pl unknown
- 2004-07-12 ES ES09167191.7T patent/ES2632515T3/es active Active
- 2004-07-12 ES ES10175143.6T patent/ES2542531T3/es active Active
- 2004-07-12 AT AT04743335T patent/ATE440620T1/de active
- 2004-07-12 DK DK09167191.7T patent/DK2133099T3/en active
- 2004-07-12 PL PL04743335T patent/PL1648518T3/pl unknown
- 2004-07-12 EP EP04743335A patent/EP1648518B1/en active Active
- 2004-07-12 DE DE602004022824T patent/DE602004022824D1/de active Active
- 2004-07-12 AU AU2004257448A patent/AU2004257448B2/en active Active
- 2004-07-12 DK DK10175140.2T patent/DK2253330T3/en active
- 2004-07-12 ES ES04743335T patent/ES2331004T3/es active Active
- 2004-07-12 KR KR1020067000278A patent/KR101152500B1/ko active IP Right Grant
- 2004-07-12 US US10/564,340 patent/US7595292B2/en active Active
- 2004-07-12 WO PCT/GB2004/002994 patent/WO2005007197A2/en active Application Filing
- 2004-07-12 ES ES10175140.2T patent/ES2549427T3/es active Active
- 2004-07-12 CN CN2004800198144A patent/CN1822860B/zh active Active
- 2004-07-12 JP JP2006518372A patent/JP4958549B2/ja active Active
- 2004-07-12 CN CN2010101399434A patent/CN101792525B/zh active Active
- 2004-07-12 EP EP09167191.7A patent/EP2133099B1/en active Active
- 2004-07-12 DK DK04743335T patent/DK1648518T3/da active
- 2004-07-12 EP EP20100175143 patent/EP2277550B1/en active Active
- 2004-07-12 DK DK10175143.6T patent/DK2277550T3/en active
-
2009
- 2009-07-28 US US12/458,931 patent/US7939630B2/en active Active
-
2010
- 2010-12-20 AU AU2010257308A patent/AU2010257308B2/en active Active
-
2011
- 2011-03-31 US US13/077,980 patent/US8816051B2/en active Active
- 2011-08-04 JP JP2011170597A patent/JP5349552B2/ja active Active
-
2014
- 2014-07-28 US US14/444,859 patent/US9439974B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0316294D0 (en) | Conjugated biological molecules and their preparation | |
| CN101200504B (zh) | 高分子巯基化改性衍生物及其交联材料 | |
| CA2191971A1 (en) | Pegylation reagents and compounds formed therewith | |
| ATE298322T1 (de) | Ss'-bis-(alpha, alpha'-disubstituierte-alpha''- essigsäure)-trithio-carbonate und derivate davon als initiatoren, kettentransfer-verbindung, kettenabbruch-verbindung für kontrollierte radikalische polymerisationen sowie verfahren zu deren herstellung | |
| WO2005065239A8 (en) | Novel recombinant proteins with n-terminal free thiol | |
| EA200000607A1 (ru) | Конъюгаты эритропоэтина | |
| NO974678D0 (no) | Heterotelechelisk blokk-kopolymer og en fremgangsmåte for fremstilling derav | |
| ATE318867T1 (de) | Thermoplastische zusammensetzung, welche einen hyperverzweigten polymer enthält, und daraus hergestellte gegenstände | |
| AU5289096A (en) | Polyethylene oxides having saccharide residue at one end and different functional group at another end, and process for producing the same | |
| BR0116381A (pt) | Conjugado, composição farmacêutica que compreende o mesmo e sua utilização, processo para o tratamento profilático e/ou terapêutico de distúrbios, processo para a preparação de um conjugado, compostos e glicoproteìnas de eritropoetina | |
| CA2326347A1 (en) | Composition and method for producing polythioethers having pendent methyl chains | |
| DE69915004D1 (de) | 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate | |
| ATE446949T1 (de) | Neues a-liponsäurederivat und dessen verwendung | |
| ATE181056T1 (de) | Arylessigsäurederivate und ihre verwendung als fungizide | |
| ATE276358T1 (de) | Polypeptid-polymer konjugat | |
| EP1167418A4 (en) | POLYOXYETHYLENE DERIVATIVES HAVING AN OPTIONALLY PROTECTED AMINO GROUP AT AN END AND A PROCESS FOR PRODUCING THE SAME | |
| EP1598384A4 (en) | NEW POLYMER AND MANUFACTURING METHOD THEREFOR | |
| Chen et al. | Synthesis and characterization of novel kinds of polyethylene oxide drugs containing 5-fluorouracil and nitrogen mustard at one end and 4-amino-N-(2-pyrimidinyl) benzene sulfonamide at the other end | |
| ATE232240T1 (de) | Verfahren zur herstellung von l-allysin acetal | |
| ATE232222T1 (de) | Verträglich machendes agens und methode zur herstellung desselben | |
| WO2002092615A3 (en) | Compositions and methods for array-based genomic nucleic acid analysis of biological molecules | |
| KR960017636A (ko) | 윤활유 조성물 | |
| WO2002002146A3 (en) | Dextrin-amphotericin conjugates and their methods of preparation | |
| DE69904940T2 (de) | 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln | |
| ATE238262T1 (de) | Zwischenprodukte für die synthese von vitamin d |